# Exo, Inc.

- Location (FDA's records): Santa Clara, CA
- FDA decisions: 5 (1983–2025): 5 510(k) clearances
- Product codes: QIH (3), FIQ (1), MYN (1)
- 510(k) review time since 2016: median 111 days, against 151 for FDA's reviews in the same codes and years (4 of 4 faster)
- Predicates its devices cite: 4 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Dia Imaging Analysis, Ltd.: 2 (https://510kreport.com/company/dia-imaging-analysis)
- Medo DX Pte., Ltd.: 1 (https://510kreport.com/company/medo-dx)
- Imagen Technologies, Inc.: 1 (https://510kreport.com/company/imagen-technologies)

## Firms that cite its devices most
- Deep Breathe, Inc.: 1 (https://510kreport.com/company/deep-breathe)
- Clarius Mobile Health Corp.: 1 (https://510kreport.com/company/clarius-mobile-health)

## Its most-cited devices
- K230497: Bladder AI (AIBV01) (2023), cited by 1
- K232501: AI Platform (AIP001) (2023), cited by 1

## Recent decisions
- K243239: Lung AI (LAI001) (Apr 24, 2025)
- K242359: Strain AI (SAI001) (Nov 20, 2024)
- K232501: AI Platform (AIP001) (Nov 17, 2023)
- K230497: Bladder AI (AIBV01) (Jun 22, 2023)
- K831801: Hemoclav Venous Catheter (Jul 7, 1983)

Source page: https://510kreport.com/company/exo